1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Θετικών Επιστημών
  4. Τμήμα Χημείας
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/9623
Full metadata record
DC FieldValueLanguage
dc.contributor.authorFilippatos, T. D.en
dc.contributor.authorLiberopoulos, E. N.en
dc.contributor.authorKostapanos, M.en
dc.contributor.authorGazi, I. F.en
dc.contributor.authorPapavasiliou, E. C.en
dc.contributor.authorKiortsis, D. N.en
dc.contributor.authorTselepis, A. D.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T16:50:35Z-
dc.date.available2015-11-24T16:50:35Z-
dc.identifier.issn1462-8902-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/9623-
dc.rightsDefault Licence-
dc.subjectfenofibrateen
dc.subjecthdl subfractionsen
dc.subjectmetabolic syndromeen
dc.subjectorlistaten
dc.subjectpre-beta1-hdlen
dc.subjectsandwich enzyme-immunoassayen
dc.subjectlow-fat dieten
dc.subjectintervention trialen
dc.subjectcholesterol effluxen
dc.subjectdiabetic-patientsen
dc.subjecthepatic lipaseen
dc.subjecthdlen
dc.subjectpre-beta-1-hdlen
dc.subjectsubclassesen
dc.subjectinsulinen
dc.titleThe effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndromeen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDOI 10.1111/j.1463-1326.2007.00733.x-
heal.identifier.secondary<Go to ISI>://000255602500005-
heal.identifier.secondaryhttp://onlinelibrary.wiley.com/store/10.1111/j.1463-1326.2007.00733.x/asset/j.1463-1326.2007.00733.x.pdf?v=1&t=h0f7uumw&s=99a398f9b534f6360017792a0a3169303b484abd-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2008-
heal.abstractObjective: We assessed the effect of orlistat and fenofibrate, alone or in combination, on plasma high-density lipoprotein (HDL) subfractions and plasma pre-beta1-HDL levels in overweight and obese subjects with metabolic syndrome (MetS). Methods: Patients (n = 89) were prescribed a low-fat low-calorie diet and were randomly allocated to receive orlistat 120 mg three times daily (O group), micronized fenofibrate 200 mg/day (F group) or both (OF group) for 6 months. HDL subfractions were determined using a polyacrylamide gel tube electrophoresis method and pre-beta1-HDL levels using enzyme-linked immunoabsorbent assay. Results: We observed a significant change of high-density lipoprotein cholesterol (HDL-C) levels only in the F group (+3%, p < 0.05). Large HDL-C levels were significantly increased and small HDL-C levels were significantly reduced with O administration. In F group we observed a significant increase of small HDL-C levels. No significant change of large or small HDL-C levels was observed with combination treatment. We observed a significant increase of pre-beta1-HDL levels in all groups, which was significantly greater in OF group compared with O or F monotherapy. Conclusion: OF combination increased the antiatherogenic pre-beta1-HDL levels in overweight and obese patients with MetS. Furthermore, OF combination counterbalanced the reduction of small HDL-C levels observed with orlistat monotherapy.en
heal.journalNameDiabetes Obesity & Metabolismen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Show simple item record
Files in This Item:
File Description SizeFormat 
Filippatos-2008-The effects of orlis.pdf108.14 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons